Organization | American Lung Association

American Lung Association Report issue

Foundation Phase 2 Phase 3 Phase 4

Founded: Chicago IL United States (1904)

Organization Overview

First Clinical Trial

2001

NCT00669383

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

American Lung Association | American Lung Association Asthma Clinical Research Centers

Active Ingredients

Drugs in Phase 4 Trials (5)

fluticasone (cutivate) (2 trials)

lansoprazole (prevacid) (2 trials)

montelukast (singulair) (1 trial)

salmeterol (serevent) (1 trial)

soy isoflavones (1 trial)

Drugs in Phase 3 Trials (1)

esomeprazole (nexium) (1 trial)

Drugs in Phase 2 Trials (9)

azithromycin (zithromax) (1 trial)

nicotine (nicorette) (1 trial)

pioglitazone (actos) (1 trial)

roflumilast (daliresp) (1 trial)

sélénium (1 trial)

vitamin a (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

zinc dichloride (1 trial)

Drugs in Other Trials (1)

betamethasone (celestone) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Asthma (Phase 4)

Bronchopulmonary Dysplasia (Phase 2)

Cough (Phase 2)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Tobacco Use Disorder (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 14
# of Trial APIs: 16